Adjuvant sunitinib in renal cell carcinoma: from evidence to recommendation

Ann Oncol. 2017 Apr 1;28(4):682-684. doi: 10.1093/annonc/mdx014.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Agents
  • Carcinoma, Renal Cell*
  • Humans
  • Indoles
  • Kidney Neoplasms
  • Pyrroles*
  • Sunitinib

Substances

  • Antineoplastic Agents
  • Indoles
  • Pyrroles
  • Sunitinib